- Home
- JILL vs CATX Comparison
JILL vs CATX Comparison
Compare JILL & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JILL
- CATX
- Stock Information
- Founded
- JILL 1959
- CATX 1983
- Country
- JILL United States
- CATX United States
- Employees
- JILL N/A
- CATX N/A
- Industry
- JILL Clothing/Shoe/Accessory Stores
- CATX Medical/Dental Instruments
- Sector
- JILL Consumer Discretionary
- CATX Health Care
- Exchange
- JILL Nasdaq
- CATX Nasdaq
- Market Cap
- JILL 233.1M
- CATX 239.0M
- IPO Year
- JILL 2017
- CATX N/A
- Fundamental
- Price
- JILL $15.09
- CATX $3.49
- Analyst Decision
- JILL Buy
- CATX Strong Buy
- Analyst Count
- JILL 3
- CATX 10
- Target Price
- JILL $18.00
- CATX $12.90
- AVG Volume (30 Days)
- JILL 71.2K
- CATX 807.4K
- Earning Date
- JILL 09-03-2025
- CATX 11-11-2025
- Dividend Yield
- JILL 2.13%
- CATX N/A
- EPS Growth
- JILL N/A
- CATX N/A
- EPS
- JILL 2.39
- CATX N/A
- Revenue
- JILL $601,713,000.00
- CATX $1,235,000.00
- Revenue This Year
- JILL $0.87
- CATX N/A
- Revenue Next Year
- JILL $2.44
- CATX N/A
- P/E Ratio
- JILL $6.31
- CATX N/A
- Revenue Growth
- JILL N/A
- CATX N/A
- 52 Week Low
- JILL $13.36
- CATX $1.60
- 52 Week High
- JILL $30.40
- CATX $13.44
- Technical
- Relative Strength Index (RSI)
- JILL 31.08
- CATX 51.86
- Support Level
- JILL $16.84
- CATX $3.33
- Resistance Level
- JILL $16.98
- CATX $3.78
- Average True Range (ATR)
- JILL 0.68
- CATX 0.21
- MACD
- JILL -0.34
- CATX 0.04
- Stochastic Oscillator
- JILL 1.07
- CATX 58.39
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.